Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Fierce Biotech

Medtronic, Biotronik heart hardware make strides in conduction system pacing

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Yahoo Finance

BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing

BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...
Healio

Novel ICD platform may benefit patients with HFrEF at risk for sudden cardiac death

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
Your Observer

Hosptial joins clinical trial of new heart failure treatment

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
KSTP-TV

Medtronic recalls over 348K defibrillators that may not work

A Minnesota-based company is recalling more than 348,000 defibrillators over concerns that they may not work. Medtronic, which has its executive headquarters based in Minneapolis, initiated the recall ...

Medtronic plc: Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...